Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times

Author:

Martinez-Gutierrez Juan Carlos1,Kim Youngran2,Salazar-Marioni Sergio3,Tariq Muhammad Bilal3,Abdelkhaleq Rania3,Niktabe Arash3,Ballekere Anjan N.3,Iyyangar Ananya S.3,Le Mai3,Azeem Hussain3,Miller Charles C.4,Tyson Jon E.5,Shaw Sandi6,Smith Peri6,Cowan Mallory6,Gonzales Isabel6,McCullough Louise D.3,Barreto Andrew D.3,Giancardo Luca7,Sheth Sunil A.3

Affiliation:

1. Department of Neurosurgery, McGovern Medical School at UTHealth, Houston, Texas

2. Center for Healthcare Data, School of Public Health, UTHealth, Houston, Texas

3. Department of Neurology, McGovern Medical School at UTHealth, Houston, Texas

4. Department of Cardiovascular and Thoracic Surgery, McGovern Medical School at UTHealth, Houston, Texas

5. Department of Pediatrics, McGovern Medical School at UTHealth Houston, Texas

6. Memorial Herman Hospital, Houston, Texas

7. UTHealth School of Biomedical Informatics, Houston, Texas

Abstract

ImportanceThe benefit of endovascular stroke therapy (EVT) in large vessel occlusion (LVO) ischemic stroke is highly time dependent. Process improvements to accelerate in-hospital workflows are critical.ObjectiveTo determine whether automated computed tomography (CT) angiogram interpretation coupled with secure group messaging can improve in-hospital EVT workflows.Design, Setting, and ParticipantsThis cluster randomized stepped-wedge clinical trial took place from January 1, 2021, through February 27, 2022, at 4 comprehensive stroke centers (CSCs) in the greater Houston, Texas, area. All 443 participants with LVO stroke who presented through the emergency department were treated with EVT at the 4 CSCs. Exclusion criteria included patients presenting as transfers from an outside hospital (n = 158), in-hospital stroke (n = 39), and patients treated with EVT through randomization in a large core clinical trial (n = 3).InterventionArtificial intelligence (AI)–enabled automated LVO detection from CT angiogram coupled with secure messaging was activated at the 4 CSCs in a random-stepped fashion. Once activated, clinicians and radiologists received real-time alerts to their mobile phones notifying them of possible LVO within minutes of CT imaging completion.Main Outcomes and MeasuresPrimary outcome was the effect of AI-enabled LVO detection on door-to-groin (DTG) time and was measured using a mixed-effects linear regression model, which included a random effect for cluster (CSC) and a fixed effect for exposure status (pre-AI vs post-AI). Secondary outcomes included time from hospital arrival to intravenous tissue plasminogen activator (IV tPA) bolus in eligible patients, time from initiation of CT scan to start of EVT, and hospital length of stay. In exploratory analysis, the study team evaluated the impact of AI implementation on 90-day modified Rankin Scale disability outcomes.ResultsAmong 243 patients who met inclusion criteria, 140 were treated during the unexposed period and 103 during the exposed period. Median age for the complete cohort was 70 (IQR, 58-79) years and 122 were female (50%). Median National Institutes of Health Stroke Scale score at presentation was 17 (IQR, 11-22) and the median DTG preexposure was 100 (IQR, 81-116) minutes. In mixed-effects linear regression, implementation of the AI algorithm was associated with a reduction in DTG time by 11.2 minutes (95% CI, −18.22 to −4.2). Time from CT scan initiation to EVT start fell by 9.8 minutes (95% CI, −16.9 to −2.6). There were no differences in IV tPA treatment times nor hospital length of stay. In multivariable logistic regression adjusted for age, National Institutes of Health Stroke scale score, and the Alberta Stroke Program Early CT Score, there was no difference in likelihood of functional independence (modified Rankin Scale score, 0-2; odds ratio, 1.3; 95% CI, 0.42-4.0).Conclusions and RelevanceAutomated LVO detection coupled with secure mobile phone application-based communication improved in-hospital acute ischemic stroke workflows. Software implementation was associated with clinically meaningful reductions in EVT treatment times.Trial RegistrationClinicalTrials.gov Identifier: NCT05838456

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3